V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213931 | 20155052 | 1.78 | 58.44 | Palliative (P) | 2019-04-16 | 2019-04-30 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 100954852 |
| 20213932 | 20155053 | 1.55 | 70.5 | Palliative (P) | null | 2018-09-27 | null | 02 | N | PANITUMUMAB | 100206870 |
| 20213933 | 20155054 | 1.82 | 87.25 | null | 2017-05-11 | 2017-06-15 | null | 02 | null | CISPLATIN + FLUOROURACIL | 101123551 |
| 20213935 | 20155055 | 1.6 | 75.6 | null | 2020-05-19 | 2020-09-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101186990 |
| 20213936 | 20155056 | 1.76 | 58.3 | Palliative (P) | null | 2017-06-04 | Panitumumab | 02 | N | PANITUMUMAB | 100773795 |
| 20213937 | 20155057 | 1.77 | 58.4 | Adjuvant (A) | 2020-03-04 | 2020-03-04 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 101778503 |
| 20213938 | 20155058 | 1.77 | 73.1 | Neo-adjuvant (N) | null | null | NIVOLUMAB | 02 | Y | NIVOLUMAB | 100039774 |
| 20213941 | 20155060 | null | null | null | 2017-09-09 | 2017-09-22 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101140170 |
| 20213945 | 20155062 | 1.72 | 92.6 | Palliative (P) | 2019-01-17 | 2019-01-20 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101695521 |
| 20213948 | 20155063 | null | 47.4 | null | null | 2021-06-24 | Panitumumab | 02 | null | PANITUMUMAB | 100241609 |
| 20213957 | 20155065 | null | 74.6 | null | null | 2016-12-27 | ECX | 02 | null | ECX | 100528369 |
| 20213960 | 20155066 | 1.77 | null | null | 2018-05-02 | 2018-05-16 | ECX | 02 | null | ECX | 100422234 |
| 20213962 | 20155067 | 1.72 | 71.8 | Palliative (P) | 2019-08-02 | 2019-08-06 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101174116 |
| 20213971 | 20155069 | null | null | Curative (C) | 2019-01-01 | 2019-01-15 | null | N | null | ECX | 100541274 |
| 20213972 | 20155070 | null | null | Adjuvant (A) | 2019-11-28 | 2019-12-05 | null | 02 | N | PANITUMUMAB | 101055746 |
| 20213974 | 20155071 | 1.8 | 84.8 | Adjuvant (A) | 2019-08-04 | 2019-08-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101542634 |
| 20213986 | 20155072 | 1.55 | 51.6 | Disease modification (D) | 2018-08-10 | 2018-08-24 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101060303 |
| 20213987 | 20155073 | 1.67 | 81.2 | Palliative (P) | 2016-05-30 | 2016-06-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101306918 |
| 20213993 | 20155076 | 1.73 | null | null | null | 2019-08-28 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101767342 |
| 20213996 | 20155077 | 1.73 | null | Palliative (P) | 2018-09-21 | 2018-10-07 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101572251 |
| 20214001 | 20155078 | 1.7 | 65 | null | 2020-01-09 | 2020-01-29 | null | 02 | null | PANITUMUMAB | 101362677 |
| 20214002 | 20155079 | null | 74.9 | Palliative (P) | null | 2021-09-29 | Panitumumab | 02 | N | PANITUMUMAB | 100792424 |
| 20214004 | 20155080 | 1.84 | 63.9 | Curative (C) | 2020-10-22 | 2020-10-22 | NIVOLUMAB | N | N | NIVOLUMAB | 101459084 |
| 20214010 | 20155081 | null | null | null | 2018-08-25 | 2018-10-21 | null | 02 | null | CISPLATIN + FLUOROURACIL | 101644129 |
| 20214014 | 20155082 | 1.65 | 75.3 | Palliative (P) | 2018-05-04 | 2018-05-04 | Panitumumab | 02 | null | CARBOPLATIN + ETOPOSIDE | 101530346 |
| 20214021 | 20155083 | 1.59 | 51.35 | Palliative (P) | 2019-12-04 | 2019-12-04 | ECX | 02 | N | ECX | 101543561 |
| 20214022 | 20155084 | 1.68 | 73 | Neo-adjuvant (N) | 2018-04-30 | 2018-05-05 | null | 02 | null | ECX | 100116619 |
| 20214030 | 20155086 | 1.74 | null | Adjuvant (A) | 2018-11-07 | 2018-11-22 | Panitumumab | 2 | null | PANITUMUMAB | 100966403 |
| 20214031 | 20155087 | 1.66 | 71.9 | null | 2016-04-14 | 2016-04-14 | null | N | null | ECX | 101769882 |
| 20214034 | 20155088 | 1.7 | 63.24 | Palliative (P) | 2020-11-18 | 2020-11-21 | null | N | N | CISPLATIN + FLUOROURACIL | 101700801 |
| 20214039 | 20155090 | null | 45.3 | Palliative (P) | 2020-11-27 | 2021-04-16 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100271930 |
| 20214042 | 20155091 | 1.57 | 85.15 | Palliative (P) | 2018-01-08 | 2018-01-16 | null | N | N | CISPLATIN + FLUOROURACIL | 101824379 |
| 20214048 | 20155092 | 1.64 | null | Palliative (P) | 2020-07-19 | 2020-08-16 | ECX | 02 | N | ECX | 100027128 |
| 20214049 | 20155093 | 1.7 | 70.8 | null | 2018-11-25 | 2018-12-13 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101243934 |
| 20214054 | 20155094 | 1.73 | 47 | null | 2020-05-01 | 2020-09-17 | Panitumumab | 02 | null | PANITUMUMAB | 101375904 |
| 20214055 | 20155095 | 1.47 | 44.5 | Palliative (P) | 2021-06-02 | 2021-06-02 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101117768 |
| 20214058 | 20155097 | 1.81 | null | Palliative (P) | 2019-04-25 | 2019-05-01 | CARBOPLATIN + ETOPOSIDE | 02 | N | ECX | 100780576 |
| 20214059 | 20155098 | 1.72 | 70 | null | 2019-01-19 | 2019-02-20 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101849592 |
| 20214060 | 20155099 | null | 71.8 | Palliative (P) | 2016-08-25 | 2017-05-25 | null | N | null | ECX | 101161973 |
| 20214062 | 20155100 | 1.71 | 73.5 | Adjuvant (A) | 2019-12-04 | 2019-12-04 | ECX | 2 | Y | ECX | 100931402 |
| 20214063 | 20155101 | 1.82 | 63.5 | Neo-adjuvant (N) | 2020-06-22 | 2020-07-05 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100150716 |
| 20214065 | 20155102 | null | null | Palliative (P) | 2017-05-18 | 2017-05-27 | ECX | N | N | ECX | 101071623 |
| 20214066 | 20155103 | 1.69 | 48 | Palliative (P) | 2018-11-06 | 2018-11-07 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101842137 |
| 20214067 | 20155104 | 1.87 | 49.8 | Palliative (P) | 2017-04-22 | 2017-04-26 | ECX | 02 | N | ECX | 100726418 |
| 20214068 | 20155105 | 1.71 | 64 | Palliative (P) | 2018-03-22 | 2018-07-05 | null | 02 | N | ECX | 100815352 |
| 20214069 | 20155106 | 1.7 | null | Neo-adjuvant (N) | 2018-05-12 | 2018-05-26 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100599960 |
| 20214073 | 20155107 | 1.67 | 51 | Adjuvant (A) | 2016-03-02 | 2016-03-02 | Panitumumab | 02 | N | PANITUMUMAB | 100561261 |
| 20214079 | 20155108 | 1.7 | 67 | Palliative (P) | 2019-01-01 | 2019-01-09 | ECX | 02 | null | ECX | 100349227 |
| 20214081 | 20155109 | 1.71 | 95.1 | Adjuvant (A) | 2020-01-27 | 2020-02-24 | null | 02 | null | PANITUMUMAB | 100828967 |
| 20214091 | 20155112 | 1.55 | 73.15 | Neo-adjuvant (N) | 2018-09-20 | 2018-10-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101349148 |